ENDOMAP
K014113 · Siemens Medical Solutions USA, Inc. · HAW · Jun 14, 2002 · Neurology
Device Facts
| Record ID | K014113 |
| Device Name | ENDOMAP |
| Applicant | Siemens Medical Solutions USA, Inc. |
| Product Code | HAW · Neurology |
| Decision Date | Jun 14, 2002 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 882.4560 |
| Device Class | Class 2 |
| Attributes | Software as a Medical Device |
Intended Use
The EndoMap package is an x-ray imaging system software option, which allows the planning of orthopedic surgeries on a workstation. The software is intended to read in diagnostic images (e.g. digitized x-rays) for use with a database of orthopedic implant geometries and dimensions. This provides a constructed image of this data, to use in conjunction with the EndoMap software to overlay the constructed images to aid surgeons in their planning of orthopedic surgeries.
Device Story
EndoMap is an x-ray imaging software option for Siemens workstations (LEONARDO, syngo, Magic View 300). Input: digitized x-ray images of pelvis and leg skeletal structures. Operation: software overlays implant geometries from a database onto patient images to facilitate surgical planning. Functions include determination of rotation center, pelvic rotation, medialization, leg length correction, reflection via body symmetric axis, biomechanical hip geometry evaluation, and coxometry. Output: constructed planning images saved to workstation database or sent to laser/paper printer. Used in clinical settings by orthopedic surgeons to adapt prostheses to patient anatomy; aids in pre-operative decision-making and surgical planning.
Clinical Evidence
No clinical data provided; bench testing only.
Technological Characteristics
Software-based orthopedic planning tool. Operates on Siemens workstations (LEONARDO, syngo, Magic View 300). Utilizes digital x-ray input and implant geometry databases. Functions include geometric measurement, rotation analysis, and image overlay. Standalone software application.
Indications for Use
Indicated for use by surgeons to plan orthopedic surgeries using digitized x-ray images and a database of implant geometries. Intended for prescription use only.
Regulatory Classification
Identification
A stereotaxic instrument is a device consisting of a rigid frame with a calibrated guide mechanism for precisely positioning probes or other devices within a patient's brain, spinal cord, or other part of the nervous system.
Predicate Devices
- VectorVision Knee (K010612)
- VectorVision Hip (K010602)
Reference Devices
- LEONARDO Workstation (K992073)
- syngo Multimodality Workstation (K010938)
Related Devices
- K042543 — IPLAN! DIGITAL TEMPLATING · Brainlab AG · May 17, 2005
- K192656 — Optimized Positioning System (OPS) Insight · Corin USA · May 1, 2020
- K142944 — ArthroPlan Digital Templating Software · Arthromeda, Inc. · Dec 16, 2014
- K173390 — hipEOS · Onefit Medical · Apr 27, 2018
- K210653 — ONE Planner Hip · Orthosoft D/B/A Zimmer Cas · Jul 7, 2021
Submission Summary (Full Text)
{0}------------------------------------------------
## 510(K) SUMMARY
Submitted by: Siemens Medical Solutions USA, Inc. 186 Wood Avenue South Iselin, NJ 08830
## December 12, 2001
This 510(k) summary of safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR § 807.92.
### 1. Contact Person
Ms. Sandra Robinson Phone: (732) 321-3243 Fax: (732) 321-4841
#### 2. Device Name and Classification
EndoMap Trade Name: Template for Clinical Use Classification Name: Classification Panel: Radiology 21 CFR § 888.4800 CFR Section: Class II. though it is defined as class I. exempt Device Class: Device Code: HWT
### 3. Intended Use
The EndoMap package is an x-ray imaging system software option, which allows the planning of orthopedic surgeries on a workstation. The software is intended to read in diagnostic images (e.g. digitized x-rays) for use with a database of orthopedic implant geometries and dimensions. This provides a constructed image of this data, to use in conjunction with the EndoMap software to overlay the constructed images to aid surgeons in their planning of orthopedic surgeries.
#### 4. Substantial Equivalence
The EndoMap is substantially equivalent to the current, commercially available BrainLabs' Vector Vision Hip, and BrainLabs' Vector Vision Knee.
| Device Name | FDA Clearance Number | FDA Clearance Date |
|-------------------|----------------------|--------------------|
| VectorVision Knee | K010612 | 09/06/2001 |
| VectorVision Hip | K010602 | 09/12/2001 |
Information that substantiates this claim of equivalence is provided throughout this 510(k) submission and specific equivalence information is provided in Attachment 5.
## 5. Device Description
The EndoMap System is a x-ray imaging software option, which allows the planning of orthopedic surgeries on several Siemens workstations such as the LEONARDO, the syngo® Multimodality Workstation and the Magic View 300. The Leonardo Workstation was described in the 510(k) premarket notification, K992073, which received FDA clearance on Sept. 09, 1999. The syngo® Multimodality Workstation K010938 received FDA clearance on June 26, 2001. The EndoMap program enables exact adaptation of the prosthesis to the existing anatomic conditions based on digital images of the pelvis and the leg skeletal structure. This is accomplished using various help functions such as determination of the rotation center and the rotation of the pelvis, medialization, leg length correction, reflection via the symmetric axis of the body, biomechanical evaluation of the hip geometry and coxometry (analysis of the hip values). The planning data can be saved to the database of the LEONARDO or other workstations and output to a laser or paper printer.
{1}------------------------------------------------
## Summary of Technological Characteristics of the Principal Device as Compared with the 6. Predicate Device
The Siemens EndoMap software package and the BrainLabs' VectorVision Hip, and BrainLabs' Vector Vision Knee software packages allows the planning of orthopedic surgeries on a workstation, which reads in diagnostic images (e.g. digitized x-rays) for use with a database of orthopedic implant geometries and dimensions.
## 7. General Safety and Effectiveness Concerns
Instructions for use are included within the device labeling and the information provided will enable the trained healthcare professional to operate the device in a safe and effective manner. Furthermore the operators are health care professionals familiar with and responsible for the planning of orthopedic surgeries to be performed.
## 8. Summary of Substantial Equivalence
In the opinion of Siemens Medical Solutions USA, Inc., the functional specifications and the substantial equivalence comparison matrix proves that the EndoMap Software is substantially equivalent to the BrainLab AG predicate Vector Vision Knee and Vector Vision Hip software.
{2}------------------------------------------------
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image shows the seal for the Department of Health & Human Services. The seal is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" around the perimeter. In the center of the seal is a stylized image of three human profiles facing to the right, with three horizontal lines above them.
Public Health Service
JUN 1 4 2002
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Ms. Sandra Robinson Siemens Medical Solutions, Inc. 186 Wood Avenue South Iselin. NJ 08830
Re: K014113
Trade/Device Name: Endomap Regulation Number: 882.4560 Regulation Name: Stereotaxic instrument Regulatory Class: II Product Code: HAW Dated: March 15, 2002 Received: March 19, 2002
Dear Ms. Robinson :
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. Iisting of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
{3}------------------------------------------------
# Page 2 - Ms. Sandra Robinson
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours.
Stipt Pluordu
Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
# INDICATIONS FOR USE
510(k) Number (if known): ____________________________________________________________________________________________________________________________________________________
Device Name: __ EndoMap
## Indications for Use:
The EndoMap package is an x-ray imaging system software option, which allows the planning of orthopedic surgeries on a workstation. The software is intended to read in diagnostic images (e.g. digitized x-rays) for use with a database of orthopedic implant geometries and dimensions. This provides a constructed image of this data, to use in conjunction with the EndoMap software to overlay the constructed images to aid surgeons in their planning of orthopedic surgeries.
Concurrence of the CDRH, Office of Device Evaluation (ODE)
Prescription Use
(per 21 CFR 801.109)
Over-The-Counter Use _________________________________________________________________________________________________________________________________________________________
Styp Rhode
OR
(Division Sign-Off Division of General, Restorative and Neurological Devices
KO14113 510(k) Number_